Morgan Ebert, Managing Editor

View our Q2 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.

Take a quick look at everything you may have missed last month, including the top FDA approvals and latest clinical updates.

A look back at the FDA submissions and regulatory decisions in the pediatric health care space from June 2025.

Mycoplasma pneumoniae caused 1 in 2 pediatric pneumonia hospitalizations in 2024, with sharp increases seen across all age groups, according to a recent CDC MMWR report.

Silver diamine fluoride and atraumatic restorative treatment stopped most cavities in NYC children, showing school-based care can reduce decay.

The FDA has approved belimumab (Benlysta; GSK) autoinjector for children with lupus nephritis, expanding at-home treatment.

Frequent exposure to cannabis and e-cigarette posts on social media is linked to increased teen cannabis and dual substance use, according to a study published in JAMA.

AAP updates clinical guidance to help pediatricians navigate genetic evaluation of children with global developmental delay or intellectual disability.

A 40-year study found that higher third-trimester glucose levels in insulin-dependent pregnancies were tied to increased obesity risk in adult offspring.

Prenatal PFAS exposure was linked to higher adolescent blood pressure according to a recent study.

The FDA has extended the review of ruxolitinib for atopic dermatitis in children 2 to 11 years to September 2025 to evaluate new CMC data.

Caffeine may protect infants from SIDS by reducing oxygen drops, offering a potential new tool alongside safe sleep practices, a recent study suggests.

Addictive use of screens—not total time—was linked to higher risks of suicidal behavior and mental health issues in early adolescents.

The American Academy of Pediatrics urges clinicians to offer confidential, adolescent-centered contraceptive care using evidence-based, equity-informed approaches.

Research presented at NUTRITION 2025 shows that fathers with improved adolescent diets are more likely to model and monitor healthy eating for their children.

A recent study found screen time and socioemotional problems in children are linked in both directions, with gaming tied to greater risk than other activities.

New research highlights how differences in state laws may be linked to changing trends in pediatric firearm mortality across the United States.

Childhood adversity may raise endometriosis risk, with exposure to violence linked to a twofold increase, a Swedish study of 1.3M women finds.

Unlike conventional carrier screening that estimates generic reproductive risk, the UNITY panel offers a direct fetal risk estimate.

Children with blood lead levels below CDC intervention thresholds had lower test scores through adolescence, a new study showed.

Take a quick look at everything you may have missed last month, including the latest FDA updates, top stories, and exclusive interviews.

A look back at the FDA submissions and regulatory decisions in the pediatric health care space from May 2025.

A recently published study found sharp increase in the use of nicotine pouches among US high school students, with usage nearly doubling from 2023 to 2024.

“These findings provide evidence that social media may be contributing to the development of depressive symptoms,” said Jason M. Nagata, MD, MSc.

These findings come as many health care professionals still report limited confidence and inconsistent practices regarding RSV immunization discussions.

Most videos on TikTok regarding hormonal contraception were misleading, according to a study presented at the 2025 ACOG Annual Clinical and Scientific Meeting.

Safety, phosphate level gains, and immunogenicity data offer encouraging signals in the pivotal trial.

Subgroup data show crinecerfont helps children with CAH reduce steroid use while maintaining or improving androstenedione levels across diverse patient groups.

Nirsevimab significantly reduces RSV-related hospitalizations, ICU admissions, and LRTIs in infants, but doesn’t shorten hospital stays, according to a recent study.

A look back at the FDA submissions and regulatory decisions in the pediatric health care space from April 2025.